对全科医生的简化药监工具的评估:5年的洞察力
A Trenque1,2, A Rabiaza2, S Fedrizzi1
1Department of Pharmacology, CHU de Caen-Normandie, 14000, Caen, France.
Scientific reports
|January 19, 2024
概括
一个简化的药监报告工具显著增加了全科医生的不良药反应 (ADR) 报告. 这种工具提高了ADR数据的数量和质量,表明更广泛的整合是有益的.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 医疗保健信息学 医疗保健信息学
背景情况:
- 自发报告对于药物监测至关重要,但由于报告不足而受到影响.
- 一般医生 (GPs) 在识别和报告药物不良反应 (ADR) 中发挥着至关重要的作用.
- 现有的报告系统可能会对及时和完整提交ADR提出障碍.
研究的目的:
- 评估一般医生用药监督简化报告工具 (PSRT) 的有效性.
- 评估PSRT对ADR报告数量和质量的影响.
- 为了比较ADR报告率在PSRT引入之前和之后.
主要方法:
- 一项前性研究比较了两个时期:一个控制期 (2010-2015年) 和一个干预期 (2015-2020年).
- 一个简化报告工具 (PSRT) 在诺曼底西部的1290名全科医生中被引入.
- 收集和分析了每月的ADR报告和报告的GP数量.
主要成果:
- 在干预期间,每月报告的ADR数量增加了3.5倍 (p < 0.0001).
- 报告的全科医生数量增加了1.4倍 (p = 0.01).
- 在干预期间的722份报告中,有一半以上 (51.8%) 使用了PSRT,这表明采用情况良好.
结论:
- 药监督简化报告工具 (PSRT) 在增加ADR报告的数量和质量方面表现出显著的有效性.
- 将PSRT集成到GP软件中可以进一步增强全国范围的ADR报告.
- 该研究强调了用户友好型工具的潜力,以改善药物安全监督.
相关概念视频
Pharmacovigilance
835
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Analysis of Population Pharmacokinetic Data
263
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
263
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


